Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Oncotarget
|
December 19, 2018
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
Kathleen I Pishas, Stephen L Lessnick
F1000Research
|
September 17, 2016
Recent advances in targeted therapy for Ewing sarcoma
Kathleen I Pishas, Stephen L Lessnick
Oncotarget
|
February 6, 2016
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
Emily R Theisen, Kathleen I Pishas, Ranajeet S Saund, et al.
Sarcoma
|
January 4, 2011
Targeting the p53 Pathway in Ewing Sarcoma
Paul M Neilsen, Kathleen I Pishas, David F Callen, et al.
ACS Chemical Biology
|
November 30, 2012
New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicity
Paul M Neilsen, Ashok D Pehere, Kathleen I Pishas, et al.
Genes & Cancer
|
March 23, 2019
Transcriptomic analysis functionally maps the intrinsically disordered domain of EWS/FLI and reveals novel transcriptional dependencies for oncogenesis
Emily R Theisen, Kyle R Miller, Iftekhar A Showpnil, et al.
Journal of Visualized Experiments : Jove
|
July 14, 2020
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Iftekhar A Showpnil, Kyle R Miller, Cenny Taslim, et al.
Oncotarget
|
June 25, 2019
Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma
Priyal O Patel, Kathleen I Pishas, Cenny Taslim, et al.
Plos Computational Biology
|
October 18, 2021
Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma
Davis T Weaver, Kathleen I Pishas, Drew Williamson, et al.
Scientific Reports
|
August 28, 2015
Erratum: XI-006 induces potent p53-independent apoptosis in Ewing sarcoma
Kathleen I Pishas, Alaknanda Adwal, Susan J Neuhaus, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Oncotarget
|
December 19, 2018
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation
Kathleen I Pishas, Stephen L Lessnick
F1000Research
|
September 17, 2016
Recent advances in targeted therapy for Ewing sarcoma
Kathleen I Pishas, Stephen L Lessnick
Oncotarget
|
February 6, 2016
Therapeutic opportunities in Ewing sarcoma: EWS-FLI inhibition via LSD1 targeting
Emily R Theisen, Kathleen I Pishas, Ranajeet S Saund, et al.
Sarcoma
|
January 4, 2011
Targeting the p53 Pathway in Ewing Sarcoma
Paul M Neilsen, Kathleen I Pishas, David F Callen, et al.
ACS Chemical Biology
|
November 30, 2012
New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicity
Paul M Neilsen, Ashok D Pehere, Kathleen I Pishas, et al.
Genes & Cancer
|
March 23, 2019
Transcriptomic analysis functionally maps the intrinsically disordered domain of EWS/FLI and reveals novel transcriptional dependencies for oncogenesis
Emily R Theisen, Kyle R Miller, Iftekhar A Showpnil, et al.
Journal of Visualized Experiments : Jove
|
July 14, 2020
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Iftekhar A Showpnil, Kyle R Miller, Cenny Taslim, et al.
Oncotarget
|
June 25, 2019
Investigating the role of LSD2 as an epigenetic regulator in Ewing sarcoma
Priyal O Patel, Kathleen I Pishas, Cenny Taslim, et al.
Plos Computational Biology
|
October 18, 2021
Network potential identifies therapeutic miRNA cocktails in Ewing sarcoma
Davis T Weaver, Kathleen I Pishas, Drew Williamson, et al.
Scientific Reports
|
August 28, 2015
Erratum: XI-006 induces potent p53-independent apoptosis in Ewing sarcoma
Kathleen I Pishas, Alaknanda Adwal, Susan J Neuhaus, et al.
Page
of 3